IGWM
IOVA icon

ICA Group Wealth Management’s Iovance Biotherapeutics IOVA Stock Holding History

ICA Group Wealth Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.16K Buy
145
+45
+45% +$482 ﹤0.01% 719
2024
Q1 		$1.48K Buy
+100
New +$1.16K ﹤0.01% 1207

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

ICA Group Wealth Management's IOVA Position: Q2 2024 in Review

ICA Group Wealth Management increased its Iovance Biotherapeutics (IOVA) stake by 45% in Q2 2024, buying an estimated $482 and bringing the position to 145 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

ICA Group Wealth Management first reported a position in IOVA in Q1 2024 and has held it in 2 quarters since. The position peaked at $1.48K in Q1 2024. 295 funds tracked by Wall St. Rank hold IOVA as of Q2 2024.

  • ICA Group Wealth Management held 145 shares of Iovance Biotherapeutics worth $1.16K as of Q2 2024.
  • ICA Group Wealth Management bought 45 Iovance Biotherapeutics shares in Q2 2024, an estimated $482.
  • Iovance Biotherapeutics made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #719 holding.
  • ICA Group Wealth Management first reported a position in Iovance Biotherapeutics in Q1 2024 and has held it in 2 quarters since.
  • ICA Group Wealth Management's Iovance Biotherapeutics position peaked at $1.48K in Q1 2024.
  • 295 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.